Professional with extensive experience in biotechnology companies
3P Biopharmaceuticals (3P), a leading Contract Development and Manufacturing Organization (CDMO) specialized in process development and cGMP manufacturing of biologics appoints a new member to the management team with the incorporation of José Luis Bartolomé as Operational Excellence and Continuous Improvement Director.
José Luis Bartolomé has a solid profile in equipment and operations management and joins 3P Biopharmaceuticals with the aim of improving the company’s internal processes.
José Luis comes to 3P with more than 30 years of experience in the biotechnology sector. He has a degree in biology from Santiago de Compostela University and throughout his extensive experience has worked in different biotechnology companies.
His professional career began in 1986 at Cooper Zeltia, and later he worked in the production department of companies such as Wellcome-Biofarma, Glaxo, Genentech and Lonza, in all of which he was a Production Manager. Before joining the 3P team, he was General Manager at Laboratorios Ovejero.
Therefore, his professional career has been developed in GMP environments, and he is an expert in the implementation of technology transfers, as well as working in facilities and processes subject to continuous customer audits or by different regulatory authorities (FDA, AEMPS, etc.)
“I appreciate the confidence 3P has shown me by giving me the opportunity to work with such a highly qualified team. I hope to contribute my experience in leading biotechnology companies to achieve excellence through continuous improvement”, explained Bartolomé.
Dámaso Molero, CEO at 3P Biopharmaceuticals said: “it is a pleasure to welcome José Luis to 3P and to incorporate such an experienced profile into our management team. I am sure that his arrival will give a boost to 3P in many aspects”.
“With my previous experience I hope to help analyze situations and processes that can be modified for our clients greater satisfaction and confidence, as well as strengthen 3P to optimize employee development and their professional growth”, added Bartolomé.
Therefore, with this new addition to the management team, 3P Biopharmaceuticals continues its growth plan and consolidates a competitive position as one of the leading CDMOs in Europe.